1. Home
  2. HLX vs VIR Comparison

HLX vs VIR Comparison

Compare HLX & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helix Energy Solutions Group Inc.

HLX

Helix Energy Solutions Group Inc.

HOLD

Current Price

$8.73

Market Cap

1.2B

Sector

Energy

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$9.29

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLX
VIR
Founded
1979
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.5B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
HLX
VIR
Price
$8.73
$9.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
8
Target Price
$10.50
$19.63
AVG Volume (30 Days)
1.9M
4.4M
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
17.49
EPS
0.21
N/A
Revenue
$876,561,000.00
$68,556,000.00
Revenue This Year
$2.91
N/A
Revenue Next Year
$4.97
$925.73
P/E Ratio
$41.62
N/A
Revenue Growth
3.60
N/A
52 Week Low
$5.52
$4.16
52 Week High
$10.75
$10.91

Technical Indicators

Market Signals
Indicator
HLX
VIR
Relative Strength Index (RSI) 48.30 56.24
Support Level $6.03 $4.95
Resistance Level $10.75 $10.91
Average True Range (ATR) 0.42 0.71
MACD -0.12 -0.03
Stochastic Oscillator 4.09 25.50

Price Performance

Historical Comparison
HLX
VIR

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. the Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: